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Error analysis is the detection, identification, and quantification 
of different types of uncertainty present in measurements and the 
propagation of this uncertainty through mathematical calculations and 
procedures.  This definition associates the term error more with 
precision and less with mistake or accuracy.  As such, error analysis 
plays a fundamental role in describing the degree of confidence in 
results derived from experiments across a variety of disciplines.  
Naturally, the importance of error analysis has grown with the 
increase in the number and heterogeneity of measurements obtained 
from newer, high-throughput, omics-level technologies. 
The increase in heterogeneity is particularly problematic for 
metabolomics, which has more heterogeneity than other omics 
technologies due to the much wider range of molecular entities 
detected and measured: thousands of distinct metabolites versus single 
classes of repetitive linear polymers like DNA, RNA, and proteins.  
Also within the context of metabolomics, error analysis has several 
fundamental uses: i) the improvement of experimental design, ii) the 
quality control of experiments, iii) the selection of appropriate 
statistical methods, and iv) the determination of uncertainty in results. 
This review will introduce the fundamental concepts of error analysis 
as they apply to a wide range of metabolomics experimental designs 
and will discuss current methodologies for determining the 
propagation of uncertainty in appropriate metabolomics data analysis, 












Owing to the confusion and misconceptions about statistical 
definitions within published metabolomics literature, I begin by 
concisely defining the main statistical terminology and concepts used 
throughout the rest of this review, but this paper is no substitute for 
more in-depth reading and study [ -3].  As shown in Table , the 
estimate of an expected value is usually represented as the mean or 
average of repeated measured values (x¯ ) of a given measured variable 
x.  The median, defined as the middle value in a sorted list of repeated 
measured values, is another common estimate of an expected value, 
often preferred when the distribution of the measured variable is 
significantly skewed (non-symmetric).  The variance σ2x represents the 
spread of these repeated measured values around this mean.  The 
standard deviation σx is just the square root of the variance.  Another 
useful term for describing uncertainty is the standard error σ x¯   (also 
known as the standard deviation of the mean), which is a probabilistic 
description of how close the mean is to the expected value. 
A related term is a confidence interval, which identifies a range 
that includes the expected value at some level of confidence (typically 
95% or 99%).  A multidimensional generalization of a confidence 
interval is a confidence region, typically approximated with an 
elliptical shape.  Both confidence intervals and confidence regions are 
especially useful descriptions of uncertainty when the probability 
distribution of the measurement(s) is unknown and clearly non-
normal.  However, the term confidence interval should not be 
confused with a tolerance interval which is more analogous to 
standard deviation and describes a range that includes a certain 
proportion of the population.  Next, covariance σ2xy describes how 
two measured variables vary together.  And correlation rxy describes 
the dependence between two measured variables.  Both of these terms 
are useful in describing the relationship between measured variables. 
Finally, the term statistical power is the probability that a 
statistical test will properly reject the null hypothesis and not make a 
false negative decision (Type II error).  A null hypothesis is a 
falsifiable assertion.  A statistical test is a method for making 
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decisions from data by deciding whether to reject a null hypothesis at 
a certain level of significance.  Statistical methods can be divided into 
parametric methods that assume an underlying probability 
distribution for the data and non-parametric methods that make no 
such assumptions and treats data from a categorical or ordinal (having 
an order or ranking) perspective.  A p-value is the probability that a 
true null hypothesis would have an observed value at a certain extreme 
or worse.  And a Type I error is the improper rejection of a null 
hypothesis, also known as a false positive.    
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The major divisions of variance in bioanalytical experiments are 
biological versus analytical variance, which categorize the source of the 
variance (Figure ).  Biological variance arises from the spread of 
measured values observed from multiple biological samples due to 
differences in individuals.  Analytical variance arises from the spread 
of measured values observed from multiple measurements made from 
the same biological sample, including all technical steps from sample 
acquisition to primary analytical data collection.  More often, the 
biological variance is significantly larger than the analytical variance. 
The major divisions of error are systematic versus nonsystematic 
(random) error, which describe the type of error.  Systematic error is a 
type of uncertainty not revealed by repeated measurements and 
represents biases in measurements that must be tested for separately in 
order to address or correct.  While systematic error does not 
appreciably affect variance, it can affect covariances and correlations 
between measured variables.  Nonsystematic error, also known as 
error variance, is the experimental uncertainty revealed by repeated 
measurements and can be reliably estimated by statistical methods.   
A third kind of variance is systematic variance, which represents 
the variance between groups of related samples in the sample set.  
Depending on the specific experiment and the applied statistical 
analysis, specific systematic variances can be part of the detectable 
signal or part of the uncertainty in the measurements due to 
confounding factors.  In other words, one scientist’s uncertainty is 
another scientist’s usable systematic variance. For example, in matched 
case-control measurements, the intergroup variance is the actual 
desired signal to detect.  In other experiments, differences in group 
composition between case-control measurements like subject sex 
(male/female) can be an additional source of confounding systematic 
variance.  In the special case when the sample set is unintentionally 
uniform (i.e. homogeneous), the group effect on the measurements 
will be systematic error and will not contribute to systematic variance.  
The classification of systematic error is further complicated by 
interpretive errors that often have the appearance of systematic error.  
The classic example is the error introduced by a “standard” 
measurement used in the correction of other measurements.   Also, 
these divisions in variance and error are not mutually exclusive (Figure 
).  Both biological and analytical variance can be divided into 
systematic variance and nonsystematic error components.   
 
Most forms of error and confounding variance in measured 
variables originate from some type of bias. This term bias refers to 
any factor that distorts the design, execution, analysis, and 
interpretation of a measurement [5] and is an ever-present problem 
for metabolomics experiments [6,7].  A bias typically causes: i) a 
systematic error that distorts the measured values but does not change 
the variance; ii) a systematic variance arising from a confounding 
factor that is either unknown or inadequately addressed; or iii) an 
interpretive error due to an inadequate or improper statistical method 
of analysis.  One can also categorize these biases as biological, 
analytical, and interpretive according to whether their effects manifest 
in the biological experiment, the analytical measurements, or 
subsequent data analysis (Figure ).   
Of the biological biases, selection bias has historically been one of 
the most problematic for case-control experiments [5], which are very 
common in metabolomics observational studies.  There are very many 
types of selection bias [5], but usually they represent an unbalanced 
selection of subjects that differ genetically or epigenetically.  Also, 
temporal selection biases (when samples are taken) are especially hard 
to control for, given the natural cycles that exist in organisms.  
Biological conditions bias is another significant type of biological bias 
where some experimental condition endured by the subjects is not 
properly controlled for or considered.   
Of the analytical biases, sample preparation bias usually presents 
the largest set of problems for the experimentalist.  Any deviation in 
how and how long a sample is extracted, quenched, and stored can 
greatly impact the measured analytes [8,9].  Standards bias represents 
the effects that different standards have on deriving some absolute or 
even relative quantification from a measurement.  Sample complexity 
bias represents the effects on measurement due to physical interaction 
between a mixture of analytes present in a sample. Analytical 
conditions bias is due to some change in analytical conditions either 
during or between measurements.   
Various interpretive biases and errors can also cause serious 
problems.  However, many of the biases are simply born out of 
ignorance or laziness.  Researchers tend to use the methods that they 
know and are easy to use, whether or not such methods are 
appropriate for the analysis.  As scientists, it is a tendency that we 
should resist.  Of the methodological biases, statistical assumptions 
about metabolomics data are most rampant.  The two worst 
assumptions are that: i) nonsystematic error is completely Gaussian 
distributed and ii) measured variables are uncorrelated.  The first 
assumption should never be made with analytical techniques like mass 
spectrometry, which by their very nature should include Poisson 
distributed error [ 0].  For NMR data, the nonsystematic error is 
often complicated and may include Lorentzian distributed 
observables, for which the variance is not analytically defined, but can 
be    numerically    estimated   [ ].    The   second   assumption   of  
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independence is unfounded given the correlation of metabolites in 
cellular metabolic networks.  Another common interpretative bias is a 
lack of statistical power due to poor design and insufficient subject 
numbers.  This situation is often confounded by a lack of correction 
for multiple testing.  Also, assignment errors like the misassignment 
of a subject to a specific group (i.e. class assignment error or class 
noise) or the misidentification of an analyte can lead to serious 
misinterpretations.   Another common interpretive bias is the use of 
preconceptions in interpretation, which can lead to a confirmation 
bias.  For example, use of unverified metabolic models (i.e. a model of 
part or all of the metabolism of one or more specific organisms) is a 
common confirmation bias in metabolic data analysis.  Also, the 
careless use of priors and limitation to expected metabolic models can 
lead to confirmation bias within a Bayesian statistical formalism [ 2].    
 
Constant vigilance is required to mitigate the many biases (Figure 
) that may add both significant systematic error and confounding 
systematic variance to a metabolomics dataset [6,7, 3].    While there 
is no simple checklist of biases to look for and procedures to follow, 
there are several straight-forward strategies for dealing with many of 
these biases.  The first is to use reasonably consistent experimental 
designs that exclude: i) partial consistencies for specific groups of 
samples, which may lead to a systematic variance from biological or 
analytical biases, and ii) trivial consistencies that may limit the 
generalization of results, due to systematic errors from biological or 
analytical biases.  Building on the first strategy, the second strategy is 
to use effective experimental designs like matched-pair case-control 
experiments to limit the effects of confounding factors, especially 
from large biological biases.  Also, the samples should be balanced 
between case-control groups for possible confounding factors (sex, 
age, related biological condition), in order to prevent systematic 
variance.  The optimal design is equally balanced sampling (i.e. 
blocking) between the most likely confounding factors within case-
control groups.  Blocking allows the use of more sophisticated 
statistical methods [ 3]: i.e. ANOVA instead of a t-test or Welch 
ANOVA [ 4] instead of a Welch’s t test [ 5].   
The third strategy is to directly test how well a set of measured 
values for a given measured variable fits an expected/assumed 
analytical nonsystematic error distribution.  Various implemented 
algorithms exist for testing how well a set of measured values fits 
different common distributions.  For example, the nortest R package 
[ 6] includes several normality (normal distribution) tests including 
the Shapiro-Wilk test [ 7] and the Anderson-Darling test [ 8]. 
The fourth strategy is to validate results with temporally-
separated datasets (i.e. analytical cross-validation) as a method for 
detecting the presence of biases.  However, failure to detect bias by 
this method does not guarantee a bias-free approach.   
The fifth strategy is to use blinded metabolomics experiments to 
reduce bias [6].  The double-blind randomized control trial is 
Figure 1. The major divisions of variance, error, and bias in bioanalytical experiments.  The expanding cone represents the effects of major types of variance 
and error on the spread (red line) and distribution of measured values.  The major divisions of variance by source are biological versus analytical variance.  The 
major divisions of error are systematic versus nonsystematic error, with a third related entity, systematic variance, representing the variance between groups 
of related samples in the sample set.  The major divisions of bias are biological, analytical, and interpretive, based upon when their effects manifest in the 
bioanalytical experiment and data analysis. 
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considered the gold standard for reducing researcher-introduced 
performance bias that can affect both biological and analytical 
conditions [ 9].  However, even this very effective method has known 
masking biases due to the psychological effects of the trial itself, 
especially when human subjects are involved [20]. Also, many 
observational studies cannot be double-blinded.  Despite this, the 
blinding of analytical and/or statistical researchers (i.e. analytical 
and/or interpretive single-blinding) can reduce performance biases 
that affect both the analytical conditions and statistical interpretation 
[2 ].     
The sixth strategy is to use analytical controls to correct for or to 
prevent analytical biases.  However, application of this strategy is 
often specific to the analytical technique and instrumentation.  With 
each sample in its own tube or vial, periodic controls or time-stamped 
near-random controls (random except to prevent neighbor effects) can 
be used to track analytical conditions during measurement [9].  For 
samples handled on plates, Latin square or 2D near-random patterns 
can be used [9].  An easier alternative representing a combination of 
strategies five and six involves the use of blind controls to detect and 
correct for several analytical biases including performance bias [22].  
For full thoroughness, often a series of controls composed of complex 
mixtures of representative or chemically similar metabolites must be 
used to determine systematic error arising from sample extraction 
methods [23] and even from interactions between the metabolites 
themselves with respect to the specific analytical techniques employed.  
The latter is particularly problematic for electrospray mass 
spectrometry. 
The seventh and final strategy is to fully document: i) the 
biological and analytical experimental procedures that produced a 
given metabolomics dataset; ii) the statistical procedures used in the 
analysis of the dataset; iii) a detailed list of all known or potential 
biases and assumptions, along with results of any analysis and testing 
of these bias and assumptions; and iv) results with adequate measures 
of uncertainty and confidence or at least a good explanation for why 
uncertainty and confidence measures are not provided.  The two most 
common explanations are that not enough replicates were collected 
for error analysis or methods to determine the propagation of 
uncertainty do not exist for a specific statistical method or procedure.  
Such documentation enables thorough evaluation and peer-review by 
others and it facilitates future meta-analyses, especially when the 
datasets and documentation are deposited into public repositories like 
MetaboLights [24].  Minimum reporting standards for metabolomics 
experiments already exist for biological (plant specific) experimental 
procedures [25], analytical experimental procedures [26], and 
statistical procedures for analysis [27]. However, it would be better to 
augment these standards, especially for reporting known and potential 
sources of bias by borrowing from well-documented clinical standards 
[6] like STARD [28] and CONSORT [29,30]. 
The overall purpose of these seven strategies is to identify which 
possible biases (Figure ) may affect the proper interpretation of a 
metabolic experiment and then to limit their effect.  However, in the 
end, a judgement call must be made on whether these strategies were 
adequate for the proper interpretation of the obtained metabolomics 




One central question that error analysis must address is whether 
nonsystematic error, variances, or covariances from either an analytical 
or biological source will prevent the desired detection and 
interpretation of biological systematic variance in a given 
metabolomics dataset.  From this perspective, any nonsystematic 
error, variance, and covariance that could interfere with biological 
interpretation represent uncertainty that should be 
determined/estimated and properly addressed.  To be most effective, 
error analysis needs to be part of the experimental design before the 
experiment even begins.  Decisions must be made on the number of 
replicates at each stage of the experimental protocol in order to have 
the necessary dataset for thorough error analysis [3 ].  In some 
instances, it will be practically impossible to obtain the necessary 
replicates for a thorough error analysis and other approaches for 
estimating sources of variance and error will be necessary.  Also, issues 
of statistical power must be considered for the statistical methods 
employed [34].  However, even when issues of statistical power are 
satisfied, typically when statistical power ≥ 0.8 at α=0.05 with 
“reasonable” statistical assumptions, it is advisable to test these 
“reasonable” assumptions by increasing analytical replicates for a 
subset of the samples.  If these assumptions do not hold true or there 
is a lack of statistical power due to large analytical variance, then 
additional steps may be taken to address these issues, including: i) 
increasing the number of analytical replicates to deal with analytical 
nonsystematic error; ii) correcting for factors that cause analytical 
systematic variance; iii) switching to appropriate statistical methods 
that do not rely on these failed assumption(s); and/or iv) 
incorporating estimates of analytical variance and covariance into 
more sophisticated statistical methods. 
So standard error analysis can be broken down into two major 
steps: i) error estimation and probability distribution testing and ii) 
error (uncertainty) propagation analysis. The first step involves the 
distribution testing, calculation/estimation, modeling, and 
comparison of nonsystematic error, variance, and covariance arising 
from biological and analytical sources.  Testing for a normal 
distribution (normality test) is by far the most important probability 
distribution test.  For normality testing, 8 to 0 replicates are 
considered the minimum needed with the Shapiro-Wilks test [35]. 
However, 20 to 30 replicates are typically desired for significant 
power, even though the Shapiro-Wilks test is considered the most 
statistically powerful normality test [ 7,36].  When a measured 
variable fails normality tests, then other non-parametric or more fault-
tolerant statistical methods should be employed to compensate for the 
lack of normality. For example, the non-parametric Wilcoxon-Mann-
Whitney test is preferred to a t-test when the data are significantly 
non-normal [37-39]; but neither test works well if the data are highly 
skewed [40].  Sometimes, it is advantageous to interpret continuous 
measured variables categorically as discreet ranges and use binomial or 
multinomial statistical tests.    
While the use of 3 analytical replicates is the minimum needed for 
quality control that includes the ability to detect outliers [9], 3 
replicates ( 2 + ) are considered the minimum for calculating 
variances with ~half-width confidence intervals at least at the 90% 
confidence level when approximately normally distributed; 30 
replicates are required to calculate variances with ~half-width 
confidence intervals at the 99% confidence level [4 ].  In addition, 
these analytical replicates will naturally lower the standard error of the 
measured variable; however, there is a practical limit due to the 
availability of analytical instrumentation or of usable sample.  Also, 
some analytical techniques have rather complex nonsystematic error 
structures that may pose additional difficulties [ 0,42].  In these 
instances, a bootstrap procedure can be used to calculate confidence 
intervals [43,44].  If the appropriate replicates across an experimental 
protocol are obtainable, then advanced mixed effect modeling 
methods can be employed to tease apart different sources of variance,  
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including from random sources [32,33,45].  However, inadequate 
number of replicates requires the use of other approaches for 
estimating variance and its sources: i.e., estimation of variance 
indirectly from similar experiments, assuming biological variance is 
any variance not directly attributable to an analytical source, and/or 
modeling variance from time series measurements [46].   
Calculating or estimating covariance is typically problematic for 
metabolomics datasets due to the small number of replicates n versus 
the number of measured variables p (n<<p). Also, reasonable 
guidelines for calculating/estimating covariances are not straight-
forward and the number of analytical replicates needed often depends 
on the number of measured variables and the amount of correlation to 
accurately detect and estimate.  One rule of thumb based on single 
correlation estimation is n ≈ 6/(ln(( +r)/( -r)))2 for detecting a 
correlation r at an α (Type I error) of 0.05 and power of 80%, but 
this rule ignores the fact that p(p- )/2 correlations are being 
estimated [4 ]. Despite these problems, there are ways to deal with 
the n<<p condition in metabolomics datasets: i) by using high 
variance of covariance to weight towards an expected covariance 
matrix structure [47]; ii) by averaging analytical covariance across 
biological replicates [3 ]; and iii) by using known variance-covariance 
relationships to estimate an analytical covariance matrix from 
calculated analytical variances [48].  
 
The propagation of uncertainty (error) through functions and 
algorithms is analyzed by two fundamentally different types of 
methods: i) mathematical (analytical) derivation and approximation 
and ii) numerical analysis.  Several software platforms exist to 
facilitate the use of these methods [49]; however, custom 
implementation of these methods is often necessary to handle specific 
issues of a given metabolomics dataset and its analysis.  With few 
exceptions, almost all analyses of error propagation via mathematical 
derivation and approximation are performed from a linear perspective 
[50].  This linear assumption is used, whether the functions and 
algorithms being analyzed are linear or nonlinear [ ].  To fully 
understand the effects of this linear perspective, we start with 
Equation , which describes the multivariate Taylor series 
approximation for a given function f.  Most error propagation 
analyses use only the 0th and st order terms, due to the exponential 
growth of higher order terms, as highlighted by the sum of sums of 
2nd order terms versus the simple sum of st order terms in Equation 
.  However for linear equations, this approach simplifies to an exact 
solution, since all 2nd order and higher terms are zero.  
In Equation 2, the approximation of y¯ (mean of f), using only the 
0th and st order terms of the series, simplifies to f applied to x¯ (mean 
of vector x).  This sets up for the approximation of σ2y (variance of f), 
again using only the 0th and st order terms of the series (Equation 3).  
The rearrangement of terms simplifies to sums of variance and 
covariance terms that approximate the effects of the variances of x on 
f using only the tangent of f at x¯ ( ∂f/∂xi(x¯ ,…, x¯ n) ).  Thus, the 
sums of variance and covariance terms are just linear approximations 
for the propagation of uncertainty through f. These sums of variance 
and covariance terms are often represented with a simpler 
vector/matrix notation (Equation 4), where Cx is the covariance 
matrix for x (sometimes called a variance-covariance matrix and 
represented as Σx).  And j(x¯ ) is the vector of partial derivatives at x¯ , 
i.e. [∂f/∂x (x¯ ), …, ∂f/∂xn(x¯ )] [5 ,52]. This concept can be further 
generalized for a system of equations y = F(x) as shown in Equation 
5, allowing the calculation of Cy using the Jacobian matrix of all first-
order partial derivatives of F at x¯ , i.e.  JF(x¯ ).  But when no 
correlation exists between xi variables, Equation 3 simplifies to just a 
sum of variance terms (or standard error terms) [2,53], which is often 
referred to as Gaussian error propagation (GEP).  It is this “no 
correlation” GEP version that underlies almost all standard error 
propagation rules [ ]. However, this GEP approximation can be very 
poor when significant correlation exists and/or for nonlinear 
functions when x¯ is near a critical point or an inflection point [50]. 
 
  
Owing to these approximation problems with nonlinear functions 
and complex algorithms or significant deviations from normality, a 
second approach to error propagation using numerical analysis is 
often more accurate and much easier to implement in these situations, 
which are typical for metabolomics data analysis.  The most common 
numerical approach is known as the Monte Carlo method, which 
samples a given function or algorithm applied to random input values 
[54].  However, from this broad definition, the Monte Carlo method 
is really a large collection of methods with a wide variety of 
applications beyond the scope of this review  [55].  Therefore, we will 
focus on a simple Monte Carlo method (Equation 6) where a set of 
pseudo-random input vectors of values (xi ϵ X) with specific 
probability distributions (Xj ~Dj) are used to generate a set of vectors 
of values (yi ϵ Y) from a given function or algorithm (f) for analyzing 
the propagation of uncertainty through f.  However, there are more 
advanced Monte Carlo approaches that can analyze the propagation 
of uncertainty from both repeated measurements and other 
information within a Bayesian framework [56].  As previously 
mentioned, it is important to characterize the probability distributions 
for the vector of input variables arising from analytical procedures via 
testing of common probability distributions and the calculation or 
estimation of expected values, variances, and correlations from 
experimental data. 
 
    (  )                     
 
With these statistical characteristics, there are several ways to 
generate a pseudo-random sampling for the input variables for 
common probability distributions.  Both Matlab [57] and R (a free, 
open source, statistical programming language that is robustly 
supported) [58] have built-in functions for generating pseudo-
random values for most of the common probability distributions  
There are also straight-forward algorithms to calculate a set of 
pseudo-random values that fit several of the common probability 
distributions using a set of uniformly distributed pseudo-random 
values (i.e. U[0, ]) [59,60].  In particular, the Box Muller method is a 
popular (easy to implement) algorithm for calculating normally 
distributed pseudo-random pairs of values from pairs which are 
U[0, ] distributed [60].  Also by definition, the inverse of a 
cumulative distribution function can be used to calculated pseudo-
random values from U[0, ] distributed values [6 ].   But care should 
be taken in selecting a good uniformly distributed random number 
generator for use in generating a given distribution.  An enhanced 
Wichmann-Hill algorithm is recommended by the current draft of the 
Guide to the Expression of Uncertainty in Measurements [62], but 
other algorithms have passed rigorous testing as well [63].  
Even pseudo-random values of complex or unknown distributions 
can be estimated using a two-sample Kolmogorov–Smirnov test (K-S 
test), which is a non-parametric test that compares the distributions of 
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two samples and determines whether they deviate significantly or not 
[64,65].  In this simple approach, sets of pseudo-random values are 
generated based on bootstrap-derived statistical parameters and tested 
against an experimentally derived set of measured values using the 
two-sample K-S test.  But there are also various approaches to 
simulate significantly non-normal multivariate random variables that 
even include correlation [66,67] or approaches that take random 
variables with given distributions and introduce correlation [68].   
Finally, with the appropriate set of pseudo-random input vectors of 
values (xi ϵ X), application of the given function or algorithm 
(Equation 6) produces a set of vectors of values (yi ϵ Y) that can be 
directly analyzed in an analogous manner as experimental data, i.e. 
probability distribution testing and calculation of expected values, 
variances, standard errors, and correlations when common probability 
distributions are present. 
If the function f is linear and X variables are (reasonably) 
independent and identically distributed (Xi ~ Xj) with finite variance, 
then Y often reflects the distribution of X (Yi ~ Xj) or even 
approximates a normal distribution for Y variables (Yi) that depend 
on many X variables (Xj).  However, if f is nonlinear, then drastically 
non-normal distributions are common for Y and quite distinct from 
X, even if X is normally distributed.  And nonlinearity is very 
common for metabolic models with exchange and bidirectional fluxes, 
which sometimes can be solved by a linearization of the model [69].  
However, in non-linearizable situations or simply when the Y 
variables are very non-normal (a multimodal distribution for 
example), a median with a confidence interval is preferable to a mean 
with a standard error, and can be estimated by a straight-forward 
approach with samples sizes of 000 or 0000, depending on the 
desired level of confidence in these confidence intervals [70].  The 
method simply orders the sampling for each Yi and takes the interval 
(y(n+ )( -c), y(n+ )c) where c is the level of confidence as a fraction (for 
example 0.95).  Likewise, a Spearman’s rank correlation coefficient 
can be used to calculate correlation in a non-parametric way in these 
situations [7 ]. 
 
Another common numerical approach used to analyze 
metabolomics data is the optimization of parameters in an inverse 
problem [72].  Often a model (g in Equation 7) with parameters (yi) 
for calculating values (xi) that are directly comparable to experimental 
data (xexp) is much easier to construct than an analytical function (f in 
Equation 6) that can calculate desired parameters from experimental 
data, especially when experimental data is collected in a time series 
[73].  For example, a model of the relevant chemical reactions for a 
“known” cellular metabolic network (to the limited degree of our 
current scientific knowledge) is more easily constructed and used to 
calculate specific metabolite fluxes and pools (mass-related 
characteristics) that can be compared to experimental values [74-76].  
These models are becoming more available and easier to use and 
modify thanks to databases like Biomodels.net and associated 
modeling tools [77,78].  However, care must be taken in the 
interpretation of the term “model”:  sometimes model refers to just 
the framework of equations (g), sometimes it refers to g and fixed 
input parameters (yi,j = cj), and sometimes it refers to g and optimized 
parameters (yopt). For the rest of this discourse, model will simply 
refer to g. 
 
x   (  )         
   
 
Equation 8 describes an objective function (Os - simple), also 
known as a target function or energy function depending on context, 
which compares the results from this model xi with experimental data 
xexp through some norm function, like an  2-norm in this instance. 
This objective function is minimized while model parameters are 
optimized to yopt using an optimization method of choice, which is 
often some type of Monte Carlo method by definition (cf. simulated 
annealing). 
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 ‖       ‖
 




However, almost all metabolomics inverse problems are ill-posed 
due to model complexity and non-linearity, limitations in the number 
and variety of measurements, and significant amounts of uncertainty 
in the measurements.  These characteristics give rise to common 
properties of ill-posed problems: i) preclusion of a unique solution yopt 
to a given set of experimental measurements xexp; ii) the existence of 
multiple solutions yopt,I; iii) the presence of discontinuities in the 
objective function; and iv)  high conditioning (i.e. large variation) in 
model parameters with respect to small changes in experimental 
measurements.  Regularization of the ill-posed objective function as a 
better-posed objective function is required to mitigate these properties 
of ill-posedness and to minimize the amplification of analytical 
uncertainty in the derived model parameters yopt during optimization.  
Without such regularization, the optimization of the objective 
function in Equation 8 quickly leads to overfitting of model 
parameters to the error in the experimental data.   However, an 
important question with regularization is how much information is 
present in the available data, and to what extent prior knowledge can 
be used to overcome limitations in the data without introducing 
undue bias?   
Tikhonov regularization is a common regularization method used 
to prevent overfitting in inverse problems, due to its effectiveness and 
simplicity of implementation [79].  Tikhonov regularization uses a 
priori knowledge of expected model parameters (yE) to allow stable 
optimization with the experimental data (xexp) while minimizing 
fitting to its error [80].  Equation 9 incorporates a Tikhonov 
regularization R(yi, yE) as a p-norm (||w||p) into Equation 8 with a 
certain weighting α, which must be kept small enough to prevent any 
significant bias to yE but large enough to prevent overfitting [79], and 
a p that properly balances between the norms ||xi|| and ||yi|| 
[8 ].    Once the issues of picking a proper α and p are overcome, 
even a confidence region around yE that includes yexact can be estimated 
with respect to ‖     ‖ 
  based on a Fisher distribution, if 
normality conditions hold and the dimensionality of xexp is 
significantly greater than the dimensionality of yE [72,82].  
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But when the analytical error for xexp can be determined, a more 
general approach for regularization can be employed, where the 
optimization is stopped when the objective function is below the 
observed analytical error [72].  One error-bounded generalized least 
squares implementation, shown in Equation 0, stops optimization 
when the objective function (Og) is below an error threshold   x. This 
threshold can be approximated by a    statistic     
 (   ), with 
n-m degrees of freedom and a p-value of -β, where n is the number 
of measured experimental variables, m is the number of parameters in 
the model, and β is the desired level of confidence.    However, this 
implementation assumes that Og(yopt) <     
 (   ), where yopt is 
determined by the lowest Og(yi).  With this assumption holding true, 
it is straight-forward to estimate the confidence region CR -β(yopt) and 
the individual confidence interval CIyj,1-β(yopt) with a large set of 
optimizations in Equations  and 2 respectively [83]. 
 
  (  )   ( (  )      )
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  ( (  )      )     
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However, this general approach in Equations 0, , and 2 only 
holds if all of the measured variables are normally distributed and the 
analytical covariance matrix Cx is known or well-estimated.  Also for 
Equation , the residuals normalized by the square root of the 
covariance matrix (i.e. normalization matrix Cx-½) should be tested for 
normality.  Plus, the optimization needs a large number of repetitions; 
however, the extra computational requirements can sometimes be 
mitigated by optimization methods that take advantage of first and 
second order partial derivatives, typically in the form of Jacobian and 
Hessian matrices [83].  If the measured experimental variables are not 
normally distributed, then it is extremely challenging to devise an 
objective function that will properly weight the residuals to a single 
error threshold and preserve the underlying distributions and 
covariance structure.  There is another Monte Carlo method that 
estimates the confidence region and confidence interval via an 
analytical estimation of the covariance matrix of y (Cy) from the 
inverse of the Jacobian matrix of g normalized by the square root of 
the analytical covariance matrix, [Cx-½Jg]- [69].  However, it suffers 
from both the need for normally distributed measured variables and 
the linear approximations made in the estimation. 
 
Equations 8 through 2 are based on the grand assumption that 
model g is “reasonably” accurate, which has the potential of being a 
very large interpretive bias.   Moreover, the faith in certain metabolic 
models is quite troubling, given the lack of verified details and errors 
in metabolic databases used in the construction of models of 
metabolic networks, especially models of eukaryotic metabolic 
networks [84].  Also, many metabolic models include more 
parameters than measured variables, which greatly limits the ability to 
verify such models.  Given these caveats, there are two general 
approaches for improving model verification: a) pare down the 
metabolic model to what is relevant to the observables; and b) design 
experiments where there are enough observables to perform model 
selection (i.e. n >> m). 
For the first approach, there are three main ways to pare down a 
metabolic model: i) gross model paring, ii) specific variable pairing by 
independence, and iii) specific variable paring by sensitivity. Gross 
model paring is simply limiting the model to relevant pathways and 
modules of a metabolic network [85], assuming that they are known.   
Specific variable pairing by independence limits the model parameters 
to the smallest set of independent or “free” model parameters from 
which other intermediate model parameters are derived [86].  An 
optimal set of free model parameters can be directly calculated via the 
determination of a basic set for the null space of the stoichiometry 
matrix [83].  Specific variable paring by sensitivity removes and/or 
simplifies parts of a model that include insensitive model parameters 
with respect to measured experimental variables.  Determining which 
model parameters are insensitive to measured experimental variables 
can be done in a directed manner by carefully removing parts of a 
model and seeing if this model change does not appreciably worsens 
the objective function nor appreciably change the optimized values of 
other model parameters [87].  Also, the relative size of model 
parameter confidence intervals can help direct this paring.  But more 
sophisticated analyses require calculating a sensitivity matrix (i.e. 
Jacobian matrix of f, Jf), which is only straight-forward when the 
direct model f (from Equation 6) can be derived [88].  However, an 
estimation of the model parameter sensitivity matrix can be calculated, 
starting with an inverse of the Jacobian matrix of g normalized by the 
square root of the analytical covariance matrix, [Cx-½Jg]- in a few steps 
[69,83].  Both of these analytical approaches represent a linear 
interpretation of sensitivity with limitations similar to analytical error 
propagation as described above. 
The second approach for improving metabolic model verification 
is to design experiments where there are significantly more 
measurables than model parameters.  For metabolomics experiments, 
this has been greatly aided by the combined use of stable isotopes 
along with analytical techniques like NMR and ultra-high resolution 
mass spectrometry that can detect the specific incorporation of these 
labeling isotopes in metabolites [89-92].   The ability to detect 
specific isotopomers by NMR and isotopologues (mass-equivalent 
sets of isotopomers) by ultra-high resolution MS, greatly increases the 
number of possible measured experimental variables and provides a 
rigorous internal normalization that obviates the need for external 
controls, when absolute quantification is not necessary.  In addition, 
there are several potential multiplicative factors on the number of 
measurable like time series measurements, the use of multiple stable 
isotopes ( 3C, 5N, 2H), and the use of multiple isotope labeling 
source metabolites.  In fact, the design of metabolomics is coming full 
circle, where metabolic models are being used to design optimal stable 
isotope labeling experiments [93-96].  However, this approach for 
metabolomics experimental design appears more robust for high 
quality metabolic models from model prokaryotic organisms.  
Once appropriate metabolic models are constructed, model 
parameters pared, and enough experimental data collected (n >> m), 
models should be verified to limit significant interpretive 
confirmation bias.   Often this verification process starts with gross 
measurement error detection via analysis of elemental and heat 
balances through the metabolic stoichiometry matrix, if the 
appropriate measurements are available [97,98].  If analytical error of 
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the experimental data can be adequately determined or estimated and 
the measured variables are approximately normally distributed, then 
the model can be further verified by a goodness-of-fit test based on a 
   statistic that reflects the number of degrees of freedom in the 
optimization and a desired level of confidence.  When Og(yopt) > 
    
 (   ) (see Equation 0), the model should be rejected, 
especially if gross measurement errors can be ruled out [83].  
However, rejection of a model is just a starting point for its 
improvement [99] and parts of the model involving parameters which 
are highly sensitive to small changes in measured variables are often a 
good place to look [83].  Eventually selection of models using 
standard methods like Akaike information criterion [ 00] should be a 
goal of the field, but these methods require approaches that limit the 
effects of overfitting during model parameter optimization, like the 




Metabolomics has a range of applications including: the discovery 
or detection of biomarkers related to a cellular, physiological, or 
disease state of interest; the generation and verification of biochemical 
mechanism-based hypotheses for biological processes and phenomena; 
and the improvement of industrial fermentation processes via 
simulation. In all of these applications, the accurate determination of 
how uncertainty propagates through data analysis is required for the 
proper evaluation of results.  Towards this end, experiments should be 
designed to minimize both biological and analytical error, to have the 
appropriate statistical power and controls, and to contain enough 
replicates to derive the analytical error and covariance, for at least a 
portion of the biological samples.  Also, data and error analyses 
should include the testing of statistical assumptions which drive the 
use of appropriate statistical methods. One excellent example that 
embodies these principles involves the use of an analytical correlation 
matrix estimated from analytical replicates and used in a maximum 
likelihood principal component analysis instead of a standard 
principal component analysis [3 ,48]. 
In addition, the reporting of results in journals and data 
repositories must accurately include the derived and propagated 
uncertainty in the results.  All p-values must be properly or at least 
conservatively adjusted under multiple testing conditions to prevent 
over-optimistic interpretation, especially in biomedical settings [7]. 
Also, p-values should be included with correlations (R2) derived from 
regression analysis.  Standard errors and confidence intervals should 
be reported for all measured and derived variables, when reasonably 
possible.  The lack of reporting confidence region/intervals for 
published metabolic model parameters is due to a host of factors 
including: the requirement for approximately normally distributed 
measured variables, a reasonable metabolic model, requirement for 
well-estimated analytical covariances, requirement for more 
measurements than model parameters, error analysis expertise, and 
computational expense.  But a few examples of reporting do exist 
([ 02] for example), which will hopefully become the norm in the 
future.  Moreover, a focus on error analysis in the development of and 
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